Nature Communications (May 2024)

Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasis

  • Udit Singhal,
  • Srinivas Nallandhighal,
  • Jeffrey J. Tosoian,
  • Kevin Hu,
  • Trinh M. Pham,
  • Judith Stangl-Kremser,
  • Chia-Jen Liu,
  • Razeen Karim,
  • Komal R. Plouffe,
  • Todd M. Morgan,
  • Marcin Cieslik,
  • Roberta Lucianò,
  • Shahrokh F. Shariat,
  • Nadia Finocchio,
  • Lucia Dambrosio,
  • Claudio Doglioni,
  • Arul M. Chinnaiyan,
  • Scott A. Tomlins,
  • Alberto Briganti,
  • Ganesh S. Palapattu,
  • Aaron M. Udager,
  • Simpa S. Salami

DOI
https://doi.org/10.1038/s41467-024-48629-y
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Localized prostate cancer is frequently composed of multiple spatially distinct tumors with significant inter- and intra-tumoral molecular heterogeneity. This genomic diversity gives rise to many competing clones that may drive the biological trajectory of the disease. Previous large-scale sequencing efforts have focused on the evolutionary process in metastatic prostate cancer, revealing a potential clonal progression to castration resistance. However, the clonal origin of synchronous lymph node (LN) metastases in primary disease is still unknown. Here, we perform multi-region, targeted next generation sequencing and construct phylogenetic trees in men with prostate cancer with synchronous LN metastasis to better define the pathologic and molecular features of primary disease most likely to spread to the LNs. Collectively, we demonstrate that a combination of histopathologic and molecular factors, including tumor grade, presence of extra-prostatic extension, cellular morphology, and oncogenic genomic alterations are associated with synchronous LN metastasis.